Intestinal surgery performed on gynecologic cancer patients

Danny Barnhill, David Doering, Steven W Remmenga, James Bosscher, John Nash, Robert Park

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

A retrospective review covering a 9-year period revealed 113 patients who underwent 157 major bowel procedures during 130 operations performed solely by gynecologic oncology surgeons. Forty-eight percent of the operations were done for tumor cytoreduction, and 33% were performed for a bowel obstruction. Other indications included colostomy closure, fistula repair, resection for multiple enterotomies, temporary diversions, repair of perforated bowel, treatment for severe proctosigmoiditis, management of ureteral stricture, treatment for vulvar necrosis, and resection of an incidental small bowel tumor. Of the 157 procedures, 44% were colostomies, 32% were bowel resections with reanastomosis, 9% were urinary conduits, 6% were intestinal bypass procedures, 5% were colostomy closures, and 4% were ileostomies. Postoperative complications occurred in 32% of the 130 operations. These included wound infection, death, sepsis, fistula formation, urinary tract infection, unexplained febrile morbidity, anastomotic leakage, stomal infarction, adult respiratory distress syndrome, bowel obstruction, deep venous thrombosis, and wound hematoma. Four of the eight deaths were due to tumor progression, three were from sepsis, and one was from adult respiratory distress syndrome. Of the 130 operations, 89 (68%) were associated with no complications. These data support the concept that gynecologic oncology surgeons are able to perform intestinal operations as therapy for gynecologic malignancies with acceptable complication rates. Since a thorough understanding of the natural history of the cancer, familiarity with alternative therapeutic options, and knowledge of the prognosis are important in making operative decisions, and since gynecologic oncologists are technically capable of performing operations on the small bowel and colon, referral of patients with a primary or recurrent gynecologic malignancy or with a subsequent intestinal complication after initial therapy should be directed to the gynecologic oncologist whenever possible.

Original languageEnglish (US)
Pages (from-to)38-41
Number of pages4
JournalGynecologic Oncology
Volume40
Issue number1
DOIs
StatePublished - Jan 1 1991

Fingerprint

Colostomy
Neoplasms
Adult Respiratory Distress Syndrome
Fistula
Sepsis
Proctocolitis
Jejunoileal Bypass
Therapeutics
Ileostomy
Anastomotic Leak
Wound Infection
Urinary Tract Infections
Venous Thrombosis
Hematoma
Infarction
Decision Making
Pathologic Constriction
Colon
Fever
Necrosis

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Cite this

Intestinal surgery performed on gynecologic cancer patients. / Barnhill, Danny; Doering, David; Remmenga, Steven W; Bosscher, James; Nash, John; Park, Robert.

In: Gynecologic Oncology, Vol. 40, No. 1, 01.01.1991, p. 38-41.

Research output: Contribution to journalArticle

Barnhill, D, Doering, D, Remmenga, SW, Bosscher, J, Nash, J & Park, R 1991, 'Intestinal surgery performed on gynecologic cancer patients', Gynecologic Oncology, vol. 40, no. 1, pp. 38-41. https://doi.org/10.1016/0090-8258(91)90082-G
Barnhill, Danny ; Doering, David ; Remmenga, Steven W ; Bosscher, James ; Nash, John ; Park, Robert. / Intestinal surgery performed on gynecologic cancer patients. In: Gynecologic Oncology. 1991 ; Vol. 40, No. 1. pp. 38-41.
@article{b4c56e9d77a74f2eb2e87bf7f053e511,
title = "Intestinal surgery performed on gynecologic cancer patients",
abstract = "A retrospective review covering a 9-year period revealed 113 patients who underwent 157 major bowel procedures during 130 operations performed solely by gynecologic oncology surgeons. Forty-eight percent of the operations were done for tumor cytoreduction, and 33{\%} were performed for a bowel obstruction. Other indications included colostomy closure, fistula repair, resection for multiple enterotomies, temporary diversions, repair of perforated bowel, treatment for severe proctosigmoiditis, management of ureteral stricture, treatment for vulvar necrosis, and resection of an incidental small bowel tumor. Of the 157 procedures, 44{\%} were colostomies, 32{\%} were bowel resections with reanastomosis, 9{\%} were urinary conduits, 6{\%} were intestinal bypass procedures, 5{\%} were colostomy closures, and 4{\%} were ileostomies. Postoperative complications occurred in 32{\%} of the 130 operations. These included wound infection, death, sepsis, fistula formation, urinary tract infection, unexplained febrile morbidity, anastomotic leakage, stomal infarction, adult respiratory distress syndrome, bowel obstruction, deep venous thrombosis, and wound hematoma. Four of the eight deaths were due to tumor progression, three were from sepsis, and one was from adult respiratory distress syndrome. Of the 130 operations, 89 (68{\%}) were associated with no complications. These data support the concept that gynecologic oncology surgeons are able to perform intestinal operations as therapy for gynecologic malignancies with acceptable complication rates. Since a thorough understanding of the natural history of the cancer, familiarity with alternative therapeutic options, and knowledge of the prognosis are important in making operative decisions, and since gynecologic oncologists are technically capable of performing operations on the small bowel and colon, referral of patients with a primary or recurrent gynecologic malignancy or with a subsequent intestinal complication after initial therapy should be directed to the gynecologic oncologist whenever possible.",
author = "Danny Barnhill and David Doering and Remmenga, {Steven W} and James Bosscher and John Nash and Robert Park",
year = "1991",
month = "1",
day = "1",
doi = "10.1016/0090-8258(91)90082-G",
language = "English (US)",
volume = "40",
pages = "38--41",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Intestinal surgery performed on gynecologic cancer patients

AU - Barnhill, Danny

AU - Doering, David

AU - Remmenga, Steven W

AU - Bosscher, James

AU - Nash, John

AU - Park, Robert

PY - 1991/1/1

Y1 - 1991/1/1

N2 - A retrospective review covering a 9-year period revealed 113 patients who underwent 157 major bowel procedures during 130 operations performed solely by gynecologic oncology surgeons. Forty-eight percent of the operations were done for tumor cytoreduction, and 33% were performed for a bowel obstruction. Other indications included colostomy closure, fistula repair, resection for multiple enterotomies, temporary diversions, repair of perforated bowel, treatment for severe proctosigmoiditis, management of ureteral stricture, treatment for vulvar necrosis, and resection of an incidental small bowel tumor. Of the 157 procedures, 44% were colostomies, 32% were bowel resections with reanastomosis, 9% were urinary conduits, 6% were intestinal bypass procedures, 5% were colostomy closures, and 4% were ileostomies. Postoperative complications occurred in 32% of the 130 operations. These included wound infection, death, sepsis, fistula formation, urinary tract infection, unexplained febrile morbidity, anastomotic leakage, stomal infarction, adult respiratory distress syndrome, bowel obstruction, deep venous thrombosis, and wound hematoma. Four of the eight deaths were due to tumor progression, three were from sepsis, and one was from adult respiratory distress syndrome. Of the 130 operations, 89 (68%) were associated with no complications. These data support the concept that gynecologic oncology surgeons are able to perform intestinal operations as therapy for gynecologic malignancies with acceptable complication rates. Since a thorough understanding of the natural history of the cancer, familiarity with alternative therapeutic options, and knowledge of the prognosis are important in making operative decisions, and since gynecologic oncologists are technically capable of performing operations on the small bowel and colon, referral of patients with a primary or recurrent gynecologic malignancy or with a subsequent intestinal complication after initial therapy should be directed to the gynecologic oncologist whenever possible.

AB - A retrospective review covering a 9-year period revealed 113 patients who underwent 157 major bowel procedures during 130 operations performed solely by gynecologic oncology surgeons. Forty-eight percent of the operations were done for tumor cytoreduction, and 33% were performed for a bowel obstruction. Other indications included colostomy closure, fistula repair, resection for multiple enterotomies, temporary diversions, repair of perforated bowel, treatment for severe proctosigmoiditis, management of ureteral stricture, treatment for vulvar necrosis, and resection of an incidental small bowel tumor. Of the 157 procedures, 44% were colostomies, 32% were bowel resections with reanastomosis, 9% were urinary conduits, 6% were intestinal bypass procedures, 5% were colostomy closures, and 4% were ileostomies. Postoperative complications occurred in 32% of the 130 operations. These included wound infection, death, sepsis, fistula formation, urinary tract infection, unexplained febrile morbidity, anastomotic leakage, stomal infarction, adult respiratory distress syndrome, bowel obstruction, deep venous thrombosis, and wound hematoma. Four of the eight deaths were due to tumor progression, three were from sepsis, and one was from adult respiratory distress syndrome. Of the 130 operations, 89 (68%) were associated with no complications. These data support the concept that gynecologic oncology surgeons are able to perform intestinal operations as therapy for gynecologic malignancies with acceptable complication rates. Since a thorough understanding of the natural history of the cancer, familiarity with alternative therapeutic options, and knowledge of the prognosis are important in making operative decisions, and since gynecologic oncologists are technically capable of performing operations on the small bowel and colon, referral of patients with a primary or recurrent gynecologic malignancy or with a subsequent intestinal complication after initial therapy should be directed to the gynecologic oncologist whenever possible.

UR - http://www.scopus.com/inward/record.url?scp=0026099173&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026099173&partnerID=8YFLogxK

U2 - 10.1016/0090-8258(91)90082-G

DO - 10.1016/0090-8258(91)90082-G

M3 - Article

VL - 40

SP - 38

EP - 41

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 1

ER -